Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Icad Inc's Business Segments
Icad Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
6
Largest Segment
Direct Sales Force
Total Revenue
$ 5
Regions Reported
-
Revenue Share by Reportable Segment - FY
- Direct Sales Force76.1%
- Subscription Term Licenses36.6%
- Services and Support33.4%
- Products and Perpetual Licenses25.5%
- OEM Partners23.9%
- Cloud Subscriptions4.4%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Direct Sales Force | $ 4 | 76.1% |
| Subscription Term Licenses | $ 2 | 36.6% |
| Services and Support | $ 2 | 33.4% |
Revenue by Product & Service Category - FY
- Product66.6%
- Subscription Term Licenses36.6%
- Services and Support33.4%
- Service33.4%
- Products and Perpetual Licenses25.5%
- Cloud Subscriptions4.4%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product | $ 3 | 66.6% |
| Subscription Term Licenses | $ 2 | 36.6% |
| Services and Support | $ 2 | 33.4% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
3 more categories available
Sign in to unlock the full Icad Inc dataset.
Annual Results
Revenue Share by Reportable Segment - FY
- Direct Sales Force76.1%
- Subscription Term Licenses36.6%
- Services and Support33.4%
- Products and Perpetual Licenses25.5%
- OEM Partners23.9%
- Cloud Subscriptions4.4%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Direct Sales Force | $ 4 | 76.1% |
| Subscription Term Licenses | $ 2 | 36.6% |
| Services and Support | $ 2 | 33.4% |
3 more segments available
Sign in to unlock the full Icad Inc dataset.
Description of Icad Inc
Icad Inc. is a medical technology company that specializes in the development and commercialization of advanced cancer detection and therapy solutions. The company was founded in 1984 and is headquartered in Nashua, New Hampshire, USA.
One of the key areas of expertise for Icad Inc. is the development of innovative and FDA-cleared cancer detection systems. The company's flagship product is the ProFound AI platform, which utilizes artificial intelligence and deep learning algorithms to enhance the accuracy and efficiency of breast cancer detection. This technology helps radiologists in the interpretation of mammograms, providing them with valuable insights and improving their diagnostic confidence.
In addition to breast cancer detection, Icad Inc. also has a significant presence in the cervical cancer screening market. The company's technology, known as the Xoft System, is a FDA-cleared miniature x-ray source that delivers localized radiation treatment for early-stage non-melanoma skin cancer and early-stage breast cancer. This system allows for precise and targeted treatment while minimizing radiation exposure to healthy tissues.
Apart from its detection and therapy solutions, Icad Inc. is actively involved in research and development to expand its product portfolio. The company invests in cutting-edge technology and collaborates with leading medical institutions and research centers to develop new products and improve existing ones. This emphasis on innovation ensures that Icad Inc. remains at the forefront of cancer detection and therapy advancements.
Icad Inc. is committed to providing comprehensive and reliable support to its customers. The company offers training and education programs to healthcare professionals, ensuring they have the necessary skills and knowledge to effectively utilize their products. Their customer service team is dedicated to providing prompt assistance and resolving any queries or concerns that customers may have.
In terms of market presence, Icad Inc. has a global footprint, with a strong presence in North America, Europe, and Asia. The company collaborates with distributors and partners to reach healthcare providers worldwide and make its advanced solutions accessible to patients.
Overall, Icad Inc. is a reputable and forward-thinking company in the field of medical technology. Through its advanced cancer detection and therapy solutions, the company aims to improve patient outcomes, enhance the efficiency of healthcare professionals, and contribute to the fight against cancer.
One of the key areas of expertise for Icad Inc. is the development of innovative and FDA-cleared cancer detection systems. The company's flagship product is the ProFound AI platform, which utilizes artificial intelligence and deep learning algorithms to enhance the accuracy and efficiency of breast cancer detection. This technology helps radiologists in the interpretation of mammograms, providing them with valuable insights and improving their diagnostic confidence.
In addition to breast cancer detection, Icad Inc. also has a significant presence in the cervical cancer screening market. The company's technology, known as the Xoft System, is a FDA-cleared miniature x-ray source that delivers localized radiation treatment for early-stage non-melanoma skin cancer and early-stage breast cancer. This system allows for precise and targeted treatment while minimizing radiation exposure to healthy tissues.
Apart from its detection and therapy solutions, Icad Inc. is actively involved in research and development to expand its product portfolio. The company invests in cutting-edge technology and collaborates with leading medical institutions and research centers to develop new products and improve existing ones. This emphasis on innovation ensures that Icad Inc. remains at the forefront of cancer detection and therapy advancements.
Icad Inc. is committed to providing comprehensive and reliable support to its customers. The company offers training and education programs to healthcare professionals, ensuring they have the necessary skills and knowledge to effectively utilize their products. Their customer service team is dedicated to providing prompt assistance and resolving any queries or concerns that customers may have.
In terms of market presence, Icad Inc. has a global footprint, with a strong presence in North America, Europe, and Asia. The company collaborates with distributors and partners to reach healthcare providers worldwide and make its advanced solutions accessible to patients.
Overall, Icad Inc. is a reputable and forward-thinking company in the field of medical technology. Through its advanced cancer detection and therapy solutions, the company aims to improve patient outcomes, enhance the efficiency of healthcare professionals, and contribute to the fight against cancer.
ICAD Inc. is a company focused on innovative imaging and radiation therapy solutions for the healthcare sector, particularly in cancer detection and treatment. The company operates primarily in two main segments: Cancer Detection and Cancer Therapy. Each segment encompasses a variety of products and services designed to enhance the efficacy of cancer screening, diagnosis, and treatment.
Segments:
1. Cancer Detection
- This segment involves advanced imaging solutions designed to assist healthcare providers in the early detection of cancer. These products leverage artificial intelligence (AI) and machine learning algorithms to improve diagnostic accuracy and enhance radiologists workflows.
Products and Services:
- AI-Based Imaging Solutions: ICAD offers AI-enabled imaging products that help in breast cancer detection through mammography and other imaging modalities. These tools assist radiologists in identifying potential tumors and abnormalities with greater precision and speed.
- SecondLook™: This is a specific product within the cancer detection segment that uses an advanced AI platform to analyze mammograms and highlight areas of concern. It acts as a decision-support tool, allowing radiologists to make more informed assessments.
- ProFound AI™: Another flagship product of ICAD, ProFound AI is specifically designed for 2D and 3D mammography. It helps detect breast cancer earlier while reducing false positives, thus streamlining the diagnostic process.
- Risk Assessment Products: In addition to direct imaging solutions, ICAD offers tools to assess patients risk factors for breast cancer, enabling personalized screening protocols.
2. Cancer Therapy
- The cancer therapy segment focuses on radiation therapy solutions designed to improve the precision and effectiveness of cancer treatment. These technologies aim to maximize tumor control while minimizing damage to surrounding healthy tissues.
Products and Services:
- RADAR™: This advanced software management platform enhances the delivery of radiation therapy by aiding in the treatment planning and optimization processes. It is designed to provide clinicians with tools for real-time data analysis and adjustment during treatment.
- Treatment Planning Software: ICAD provides comprehensive solutions for treatment planning in radiation therapy. These programs help clinicians design personalized treatment plans for patients, considering various factors such as tumor size, location, and type.
- Radiation Therapy Delivery Systems: The company offers systems that can be integrated into existing radiation therapy equipment, allowing for more precise targeting and delivery of radiation doses.
- Patient Monitoring and Support Services: ICAD includes various services aimed at supporting patients throughout their treatment journey, including educational materials, support groups, and follow-up care.
Research and Development:
ICAD invests heavily in research and development to expand its product offerings and enhance existing solutions. This commitment to innovation ensures that it stays at the forefront of cancer detection and therapy technologies. The R&D team focuses on integrating the latest scientific advancements into their products, including advancements in AI, machine learning, and imaging technologies.
Partnership and Collaborations:
ICAD actively seeks partnerships with healthcare organizations, research institutions, and technology providers. These collaborations aim to enhance product development, facilitate clinical trials, and expand the reach of ICAD’s innovative solutions in the market.
Customer Base:
ICAD targets a wide range of customers within the healthcare industry, including hospitals, cancer treatment centers, radiology clinics, and medical imaging facilities. The products are designed to cater to healthcare professionals, radiologists, oncologists, and patients, streamlining the workflow for medical practitioners and improving patient outcomes.
By offering a comprehensive suite of products and services in cancer detection and therapy, ICAD Inc plays a vital role in enhancing the standards of care provided to patients, thereby contributing to improved cancer management and treatment practices.
Segments:
1. Cancer Detection
- This segment involves advanced imaging solutions designed to assist healthcare providers in the early detection of cancer. These products leverage artificial intelligence (AI) and machine learning algorithms to improve diagnostic accuracy and enhance radiologists workflows.
Products and Services:
- AI-Based Imaging Solutions: ICAD offers AI-enabled imaging products that help in breast cancer detection through mammography and other imaging modalities. These tools assist radiologists in identifying potential tumors and abnormalities with greater precision and speed.
- SecondLook™: This is a specific product within the cancer detection segment that uses an advanced AI platform to analyze mammograms and highlight areas of concern. It acts as a decision-support tool, allowing radiologists to make more informed assessments.
- ProFound AI™: Another flagship product of ICAD, ProFound AI is specifically designed for 2D and 3D mammography. It helps detect breast cancer earlier while reducing false positives, thus streamlining the diagnostic process.
- Risk Assessment Products: In addition to direct imaging solutions, ICAD offers tools to assess patients risk factors for breast cancer, enabling personalized screening protocols.
2. Cancer Therapy
- The cancer therapy segment focuses on radiation therapy solutions designed to improve the precision and effectiveness of cancer treatment. These technologies aim to maximize tumor control while minimizing damage to surrounding healthy tissues.
Products and Services:
- RADAR™: This advanced software management platform enhances the delivery of radiation therapy by aiding in the treatment planning and optimization processes. It is designed to provide clinicians with tools for real-time data analysis and adjustment during treatment.
- Treatment Planning Software: ICAD provides comprehensive solutions for treatment planning in radiation therapy. These programs help clinicians design personalized treatment plans for patients, considering various factors such as tumor size, location, and type.
- Radiation Therapy Delivery Systems: The company offers systems that can be integrated into existing radiation therapy equipment, allowing for more precise targeting and delivery of radiation doses.
- Patient Monitoring and Support Services: ICAD includes various services aimed at supporting patients throughout their treatment journey, including educational materials, support groups, and follow-up care.
Research and Development:
ICAD invests heavily in research and development to expand its product offerings and enhance existing solutions. This commitment to innovation ensures that it stays at the forefront of cancer detection and therapy technologies. The R&D team focuses on integrating the latest scientific advancements into their products, including advancements in AI, machine learning, and imaging technologies.
Partnership and Collaborations:
ICAD actively seeks partnerships with healthcare organizations, research institutions, and technology providers. These collaborations aim to enhance product development, facilitate clinical trials, and expand the reach of ICAD’s innovative solutions in the market.
Customer Base:
ICAD targets a wide range of customers within the healthcare industry, including hospitals, cancer treatment centers, radiology clinics, and medical imaging facilities. The products are designed to cater to healthcare professionals, radiologists, oncologists, and patients, streamlining the workflow for medical practitioners and improving patient outcomes.
By offering a comprehensive suite of products and services in cancer detection and therapy, ICAD Inc plays a vital role in enhancing the standards of care provided to patients, thereby contributing to improved cancer management and treatment practices.